These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 377109)

  • 1. Effect of M.bovis BCG and M.microti on sarcoma 180 growth in mice.
    Nedvĕdová V; Sír Z; Hyncica V; Buresová M
    Neoplasma; 1978; 25(6):685-90. PubMed ID: 377109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phagocytosis of Mycobacterium bovis BCG organisms by murine S180 sarcoma cells.
    Devadoss PO; Klegerman ME; Groves MJ
    Cytobios; 1993; 74(296):49-58. PubMed ID: 8330487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The genetic regulation of host response to inoculation with Mycobacterium bovis (BCG) and Mycobacterium tuberculosis H37RV].
    Nikonenko BV; Mezhlumova MB; Moroz AM
    Biull Eksp Biol Med; 1990 Nov; 110(11):526-8. PubMed ID: 2128037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ultrastructure of the strain BCG 725 cultivated on Sauton's medium with casein hydrolysate. Co-report the report "biochemistry of BCG lipids and their role in antituberculous immunity and hypersensitivity.
    Mohelská H
    J Hyg Epidemiol Microbiol Immunol; 1975; 19(4):453-7. PubMed ID: 1107418
    [No Abstract]   [Full Text] [Related]  

  • 5. BCG immunization for the lymphoid leukemia line (LSTRA) in CDF1 mice.
    Chaparas SD; Chirigos M; Pearson J; Sher N
    Natl Cancer Inst Monogr; 1973 Dec; 39():87-8. PubMed ID: 4595328
    [No Abstract]   [Full Text] [Related]  

  • 6. The efficacy of live tuberculosis vaccines after presensitization with Mycobacterium avium.
    de Lisle GW; Wards BJ; Buddle BM; Collins DM
    Tuberculosis (Edinb); 2005; 85(1-2):73-9. PubMed ID: 15687030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycobacterium avium subsp. paratuberculosis-specific mpt operon expressed in M. bovis BCG as vaccine candidate.
    Heinzmann J; Wilkens M; Dohmann K; Gerlach GF
    Vet Microbiol; 2008 Aug; 130(3-4):330-7. PubMed ID: 18343053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Myobacterium bovis (strain Bacillus Calmette-Guérin) on macrophage production by the bone marrow of tumor-bearing mice.
    Fisher B; Taylor S; Levine M; Saffer E; Fisher ER
    Cancer Res; 1974 Jul; 34(7):1668-70. PubMed ID: 4599359
    [No Abstract]   [Full Text] [Related]  

  • 9. Growth of sarcoma 180 in normal and splenectomized BALB/c mice immunized with BCG.
    Rumi LS; García MS; Barañao RI; Schwint AE
    Acta Physiol Lat Am; 1982; 32(2):123-30. PubMed ID: 6763450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low molecular weight water-soluble peptidoglycans as adjuvants and immunostimulants.
    Jollès P; Migliore-Samour D; Maral R; Floc'h F; Werner GH
    Z Immunitatsforsch Exp Klin Immunol; 1975 Jul; 149(2-4):331-40. PubMed ID: 241167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effects of BCG and other bacteria against neoplasia in mice and hamsters.
    Lemonde P
    Natl Cancer Inst Monogr; 1973 Dec; 39():21-32. PubMed ID: 4362522
    [No Abstract]   [Full Text] [Related]  

  • 12. Environmental strains of Mycobacterium avium interfere with immune responses associated with Mycobacterium bovis BCG vaccination.
    Young SL; Slobbe L; Wilson R; Buddle BM; de Lisle GW; Buchan GS
    Infect Immun; 2007 Jun; 75(6):2833-40. PubMed ID: 17371857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapeutic studies in mice with the methanol-extraction residue (mer) fraction of BCG: solid tumors.
    Yron I; Weiss DW; Robinson E; Cohen D; Adelberg MG; Mekori T; Haber M
    Natl Cancer Inst Monogr; 1973 Dec; 39():33-55. PubMed ID: 4362523
    [No Abstract]   [Full Text] [Related]  

  • 14. Relative tumor inhibitory and stimulatory activities of BCG vaccine preparations, lots and substrains in a quantitative mouse sarcoma bioassay.
    Klegerman ME; Zeunert PL; Lajeune J; Lou Y; Groves MJ
    Anticancer Res; 1991; 11(5):1707-10. PubMed ID: 1768040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced protection against tuberculosis by vaccination with recombinant Mycobacterium microti vaccine that induces T cell immunity against region of difference 1 antigens.
    Brodin P; Majlessi L; Brosch R; Smith D; Bancroft G; Clark S; Williams A; Leclerc C; Cole ST
    J Infect Dis; 2004 Jul; 190(1):115-22. PubMed ID: 15195250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a Mycobacterium bovis intranasal challenge model in mice.
    Logan KE; Gavier-Widen D; Hewinson RG; Hogarth PJ
    Tuberculosis (Edinb); 2008 Sep; 88(5):437-43. PubMed ID: 18590980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First data on Eurasian wild boar response to oral immunization with BCG and challenge with a Mycobacterium bovis field strain.
    Ballesteros C; Garrido JM; Vicente J; Romero B; Galindo RC; Minguijón E; Villar M; Martín-Hernando MP; Sevilla I; Juste R; Aranaz A; de la Fuente J; Gortázar C
    Vaccine; 2009 Nov; 27(48):6662-8. PubMed ID: 19747578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exposure to Mycobacterium avium can modulate established immunity against Mycobacterium tuberculosis infection generated by Mycobacterium bovis BCG vaccination.
    Flaherty DK; Vesosky B; Beamer GL; Stromberg P; Turner J
    J Leukoc Biol; 2006 Dec; 80(6):1262-71. PubMed ID: 16968819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Mycobacterium bovis BCG-Praha on the growth of transplanted Daels' sarcoma in guinea-pigs.
    Schwartz E
    Neoplasma; 1973; 20(4):375-86. PubMed ID: 4580793
    [No Abstract]   [Full Text] [Related]  

  • 20. Antineoplastic activity of BCG: location of antineoplastic glycans in the cellular integument of Mycobacterium bovis, BCG vaccine, Connaught substrain.
    Garrido JL; Klegerman ME; Reyes HR; Groves MJ
    Cytobios; 1997; 90(360):47-65. PubMed ID: 9438337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.